Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The LEADER trial 28 (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) studied a 1.8-mg dose in more than 9,000 patients with type 2 diabetes and found the incidence of acute pancreatitis was similar between the liraglutide and placebo groups (0.4% vs 0.5%, respectively)
Key points The incretins glucagon-like peptide 1 (GLP1) and glucose-dependent insulinotropic peptide (GIP) and related hormones such as glucagon and amylin regulate metabolism, gastrointestinal motility, appetite and body weight
Heres what you need to know about how each one is taken
By application, the type 2 diabetes mellitus segment led the global GLP-1 receptor agonist market in 2025
The profibrotic mechanism of ferroptosis is closely related to the TGF-/Smad pathway, and targeting ferroptosis and increasing GPX4 expression could be an effective strategy for treating CKD
